Life Sciences Virtual Networking Event Recap | June 17, 2021
Once again, the Global Life Sciences Alliance (GLSA) and FOCM Networking hosted a successful virtual networking event on June 17, 2021. As a result, attendees felt more comfortable with the format and Zoom breakout rooms. Overall, the session was smooth, engaging, and productive.
To begin, we reviewed highlights from the May event. Next, we outlined the agenda and meeting guidelines. After that, Chris introduced GLSA members to the broader FOCM community, setting a collaborative tone for the evening.
Following introductions and open discussion, our Zoom Room Administrator, Brandon, assigned attendees into breakout rooms of four people each. Initially, the plan was to run 10-minute sessions. However, based on feedback from Joe, we extended them to 12 minutes. This small change allowed for deeper conversation and proved very effective.
Then, the evening moved into “speed networking” mode. Chris shared the idea that most clinical research professionals are only two degrees of separation from one another. Throughout three breakout rotations, attendees introduced themselves, shared their backgrounds, and discussed how they could support each other.
As a result, conversations were lively and meaningful. Valuable insights were exchanged. More importantly, several new connections were formed. These relationships can help strengthen collaboration and improve clinical trial execution across the industry.
Attendees
-
Joe Buser, GLSA
-
Jon Matheus, Pancrazi Real Estate
-
Denise McNerney, GLSA
-
Kevin Boos, Rho
-
Zulma Varela, GLSA
-
Mike O’Gorman, Life Science Marketplace
-
Ken Paley, Docutrial
-
Bill Dirkes, Docutrial
-
Scott Freedman, Monitor For Hire
-
Ted Gastineau, Invicro
-
Brandon Huffman, GLSA
-
Kevin Collier, Medidata
-
Jim Choi, CRSCube
-
Michael Young, biomedwoRx
-
Daryl Oberg, GLSA
-
Holly Cliffe, GLSA
About GLSA
Global Life Sciences Alliance (GLSA) connects biotechs, pharma, CROs, and clinical research sites with the right experts, advisors, and solutions to accelerate development and reduce risk. With a network of more than 200 trusted partners spanning pre-clinical and clinical research, GLSA offers flexible, cost-effective access to specialized expertise and services that support early-stage biotechs, mid-size pharma, and global pharmaceutical companies.
When you need trusted, global resources to accelerate your research, GLSA helps you scale smarter and move you forward with confidence.
To learn how GLSA can support your organization, connect with Denise McNerney or Chris Matheus for a conversation about your goals and challenges.